492
M.-J. Suh et al.
LETTER
114.6, 126.6, 126.7, 128.1, 141.8, 144.6, 151.6. HRMS (EI)
calcd for C19H24N2O: 296.1889. Found: 296.1883. Anal.
Calcd. for C19H24N2O: C, 77.0; H, 8.16; N, 9.45. Found: C,
76.8; H, 8.09; N, 9.42. Compound 2f: colorless oil, [a]D 18.9
(c 3.0 in EtOAc). 1H NMR (200 MHz, CDCl3): d = 1.08 (d,
J = 6.8 Hz, 3 H), 1.19 (d, J = 6.2 Hz, 1 H), 1.66–1.78 (m, 2
H), 2.25 (q, J = 6.6 Hz, 1 H), 3.55 (s, 3 H), 4.04–4.08 (m, 1
H), 6.35–6.57 (m, 4 H), 7.10–7.33 (m, 10 H). 13C NMR (50.3
MHz, CDCl3): d = 23.6, 31.5, 45.4, 55.6, 58.9, 69.1, 114.6,
114.8, 126.5, 126.7, 127.0, 127.1, 128.3, 128.5, 141.5,
142.8, 144.3, 151.7. HRMS (EI) calcd for C24H26N2O:
358.2045. Found: 358.2049.
Acknowledgment
We gratefully acknowledge the financial support of the following
institutions: The Korea Science and Engineering Foundation (R01-
2000-000-00048-0 and CBMH to HJH and R14-2002-045-010020
to WKL), and the Korea Research Foundation (KRF-2002-070-
C00060 to WKL and HJH).
References
(1) For reviews, see: (a) Sweeney, J. B. Chem. Soc. Rev. 2002,
31, 247. (b) Zwanenburg, B.; ten Holte, P. In Stereoselective
Heterocyclic Chemistry III; Metz, P., Ed.; Springer: Berlin,
2001, 93–124. (c) McCoull, W.; Davis, F. A. Synthesis
2000, 1347. (d) Osborn, H. M. I.; Sweeney, J. B.
(10) Park, C. S.; Kim, M. S.; Sim, T. B.; Pyun, D. K.; Lee, C. H.;
Choi, D.; Lee, W. K.; Chang, J.-W.; Ha, H.-J. J. Org. Chem.
2003, 68, 43.
(11) (a) Alexakis, A.; Lensen, N.; Mangeney, P. Tetrahedron
Lett. 1991, 32, 1171. (b) Alexakis, A.; Lensen, N.;
Tranchier, J.-P.; Mangeney, P. J. Org. Chem. 1992, 57,
4563. (c) Alexakis, A.; Lensen, N.; Tranchier, J.-P.; Pierre,
M.; Mangeney, P.; Feneau-Dupont, J.; Declercq, J. P.
Synthesis 1995, 1038. (d) Alexakis, A.; Tranchier, J.-P.;
Lensen, N.; Mangeney, P. J. Am. Chem. Soc. 1995, 117,
10767.
(12) Sapse, A. M.; Bunce, J. D.; Jain, D. C. J. Am. Chem. Soc.
1984, 106, 6579.
(13) Dong, Y.; Yun, H.; Park, C. S.; Lee, W.-K.; Ha, H.-J. Acta
Crystallogr., Sect. C 2003, 59, 659.
Tetrahedron: Asymmetry 1997, 8, 1693. (e) Pearson, W. H.;
Lian, B. W.; Bergmeier, S. C. In Comprehensive
Heterocyclic Chemistry II, Vol. 1A; Padwa, A., Ed.;
Pergamon Press: New York, 1996, 1. (f) Tanner, D. Angew.
Chem., Int. Ed. Engl. 1994, 33, 599.
(2) Lee, W.-K.; Ha, H.-J. Aldrichimica Acta 2003, 36, 57.
(3) Hwang, G. I.; Chung, J.-H.; Lee, W. K. J. Org. Chem. 1996,
61, 6183.
(4) Yun, J. M.; Sim, T. B.; Hahm, H. S.; Lee, W. K.; Ha, H.-J.
J. Org. Chem. 2003, 68, 7675.
(5) For reviews, see: (a) Alvoro, G.; Savoia, D. Synlett 2002,
651. (b) Bloch, R. Chem. Rev. 1998, 98, 1407. (c) Ender,
D.; Reinhold, U. Tetrahedron: Asymmetry 1997, 8, 1895.
(d) For recent examples, see: Saito, S.; Hatanaka, K.;
Yamamoto, H. Synlett 2001, 1859. (e) Wang, D.-K.; Dai,
L.-X.; Hou, X.-L.; Zhang, Y. Tetrahedron Lett. 1996, 37,
4187. (f) Bambridge, K.; Begley, M. J.; Simpkins, N. S.
Tetrahedron Lett. 1994, 35, 3391.
(6) Lucet, D.; Gall, T. L.; Mioskowski, C. Angew. Chem. Int.
Ed. 1998, 37, 2580.
(7) (a) Shimizu, M.; Suzuki, I.; Makino, H. Synlett 2003, 1635.
(b) Bhattarai, K.; Cainelli, G.; Panunzio, M. Synlett 1990,
229. (c) Jacob, P.; Callery, P. S.; Shulgin, A. T.; Castagnoli,
N. J. Org. Chem. 1976, 41, 3627.
(8) (a) Alvaro, G.; Pacioni, P.; Savoia, D. Chem.–Eur. J. 1997,
3, 726. (b) Wada, M.; Sakurai, Y.; Akiba, K.-y. Tetrahedron
Lett. 1984, 25, 1079.
(9) General Procedure for the Addition Reactions of Alkyl
or Aryl Magnesium Bromide: Into the solution of (p-
methoxyphenyl)-{[1¢(R)-a-methylbenzyl]aziridine-2(R)-
ylmethylene}amine (280 mg, 1 mmol) in of Et2O (10 mL)
was added ethereal solution of alkyl or aryl magnesium
bromide (3 mmol) and BF3·OEt2 (0.15 mL, 0.8 mmol) under
N2 atmosphere. The resultant solution was stirred at –10 °C
for the reaction to be completed before being quenched by
adding ice-water. The reaction product was isolated with
Et2O (15 mL × 4). The ethereal solution was washed with
brine twice. The organic layer was dried over anhyd MgSO4,
filtered and concentrated under reduced pressure.
Purification by silica gel flash column chromatography
provided the analytically pure addition product. Compound
2a: colorless oil, [a]D 33.5 (c 2.0 in EtOAc). 1H NMR (200
MHz, CDCl3): d = 1.12 (d, J = 6.0 Hz, 1 H), 1.14 (d, J = 4.2
Hz, 3 H), 1.22 (d, J = 6.2 Hz, 3 H), 1.54–1.62 (m, 2 H), 2.36
(q, J = 6.6 Hz, 1 H), 3.32–3.41 (m, 1 H), 3.63 (s, 3 H), 6.52–
6.71 (m, 4 H), 7.14–7.31 (m, 5 H). 13C NMR (50.3 MHz,
CDCl3): d = 19.5, 23.5, 30.4, 44.2, 48.9, 55.6, 69.3, 114.6,
(14) General Procedure for the Synthesis of 5-Aalkyl or 5-
Aryl-4-chloromethylimidazolidin-2-one: To a solution of
{1-[1¢(R)-a-methylbenzyl]aziridin-2(R)-yl}-methylamine
(310 mg, 1.05 mmol) in 15 mL of THF under nitrogen
atmosphere was added NaH (144 mg, 6 mmol) at –10 °C.
The mixture was stirred for 1 h at –10 °C. To the mixture
was slowly added triphosgene solution (0.356 g, 1.2 mmol)
in THF (5 mL) at –10 °C. The mixture was stirred for 2 h at
–10 °C. The reaction was quenched with H2O at –10 °C and
warmed to r.t. The aqueous layer was extracted with CH2Cl2
(10 mL × 5). The combined organic extract was dried over
MgSO4 and the solvent was evaporated in vacuo to give the
crude product as a white solid which was purified by silica
gel flash chromatography to give analytically pure product.
Compound 6a: colorless oil. 1H NMR (200 MHz, CDCl3):
d = 0.82 (d, J = 6.2 Hz, 3 H), 1.50 (d, J = 7.4 Hz, 3 H), 2.92
(dt, J = 7.0 Hz, 3.2 Hz, 1 H), 3.32 (dd, J = 11.4 Hz, 7.6 Hz,
1 H), 3.42 (dd, J = 11.4 Hz, 3.2 Hz, 1 H), 3.65 (s, 3 H), 3.90
(qd, J = 6.2 Hz, J = 3.2 Hz, 1 H), 5.25 (q, J = 7.4 Hz, 1 H),
6.72–6.78 (m, 2 H), 7.11–7.27 (m, 7 H). 13C NMR (50.3
MHz, CDCl3): d = 18.7, 19.4, 45.5, 51.2, 54.6, 55.4, 58.8,
114.1, 123.1, 127.3, 127.7, 128.6, 131.4, 139.8, 156.2,
156.8. HRMS (EI) calcd for C20H23ClN2O2: 358.1448.
Found: 358.1453.
(15) (a) Lim, Y.; Lee, W. K. Tetrahedron Lett. 1995, 36, 8431.
(b) Hayashi, K.; Nunami, K.-i.; Kato, J.; Yoneda, N.; Kubo,
M.; Ochiai, T.; Ishida, R. J. Med. Chem. 1989, 32, 289.
(c) Shidari, M.; Pusino, A.; Gessa, C.; Cacco, G. J. Agric.
Food Chem. 1998, 46, 2800. (d) Robinson, R. P.; Laird, E.
R.; Donahue, K. M.; Lopresti-Morrow, L. L.; Mitchell, P.
G.; Reese, M. R.; Reeves, L. M.; Rouch, A. I.; Stam, E. J.;
Yocum, S. A. Bioorg. Med. Chem. Lett. 2001, 11, 1211.
(e) Yasar, S.; Bergman, J.; Munzar, P.; Redhi, G.; Tober, C.;
Knobel, N.; Zschiesche, M.; Paronis, C. Eur. J. Pharm.
2003, 465, 257.
Synlett 2004, No. 3, 489–492 © Thieme Stuttgart · New York